These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31271515)

  • 1. Discoidin domain receptors: A promising target in melanoma.
    Reger de Moura C; Battistella M; Sohail A; Caudron A; Feugeas JP; Podgorniak MP; Pages C; Mazouz Dorval S; Marco O; Menashi S; Fridman R; Lebbé C; Mourah S; Jouenne F
    Pigment Cell Melanoma Res; 2019 Sep; 32(5):697-707. PubMed ID: 31271515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1.
    Reger De Moura C; Louveau B; Jouenne F; Vilquin P; Battistella M; Bellahsen-Harrar Y; Sadoux A; Menashi S; Dumaz N; Lebbé C; Mourah S
    Oncogene; 2024 May; 43(21):1620-1630. PubMed ID: 38570692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma.
    Hur H; Ham IH; Lee D; Jin H; Aguilera KY; Oh HJ; Han SU; Kwon JE; Kim YB; Ding K; Brekken RA
    BMC Cancer; 2017 Jan; 17(1):87. PubMed ID: 28143619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of DDR1 reduces invasive features of human A375 melanoma, HT29 colon carcinoma and SK-HEP hepatoma cells.
    Romayor I; Badiola I; Olaso E
    Cell Adh Migr; 2020 Dec; 14(1):69-81. PubMed ID: 32090682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway.
    Pan Y; Han M; Zhang X; He Y; Yuan C; Xiong Y; Li X; Zeng C; Lu K; Zhu H; Lu X; Liu Q; Liang H; Liao Z; Ding Z; Zhang Z; Chen X; Zhang W; Zhang B
    Cell Oncol (Dordr); 2022 Feb; 45(1):163-178. PubMed ID: 35089546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of DDR1 with antibody-drug conjugates has antitumor effects in a mouse model of colon carcinoma.
    Tao Y; Wang R; Lai Q; Wu M; Wang Y; Jiang X; Zeng L; Zhou S; Li Z; Yang T; Yao Y; Wu Y; Yu L; Fu Y; Lai W; Peng Y; Lu Y; Zhang Z; Guo C; Zhang G; Gou L; Yang J
    Mol Oncol; 2019 Sep; 13(9):1855-1873. PubMed ID: 31116512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-Regulation of DDR1 Induces Apoptosis and Inhibits EMT through Phosphorylation of Pyk2/MKK7 in DU-145 and Lncap-FGC Prostate Cancer Cell Lines.
    Azizi R; Fallahian F; Aghaei M; Salemi Z
    Anticancer Agents Med Chem; 2020; 20(8):1009-1016. PubMed ID: 32275493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis.
    Valencia K; Ormazábal C; Zandueta C; Luis-Ravelo D; Antón I; Pajares MJ; Agorreta J; Montuenga LM; Martínez-Canarias S; Leitinger B; Lecanda F
    Clin Cancer Res; 2012 Feb; 18(4):969-80. PubMed ID: 22223527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells.
    Song J; Chen X; Bai J; Liu Q; Li H; Xie J; Jing H; Zheng J
    Tumour Biol; 2016 Aug; 37(8):11509-21. PubMed ID: 27020590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice.
    Sun X; Gupta K; Wu B; Zhang D; Yuan B; Zhang X; Chiang HC; Zhang C; Curiel TJ; Bendeck MP; Hursting S; Hu Y; Li R
    J Biol Chem; 2018 Feb; 293(8):2841-2849. PubMed ID: 29298894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability.
    Badiola I; Villacé P; Basaldua I; Olaso E
    Oncol Rep; 2011 Oct; 26(4):971-8. PubMed ID: 21701781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.
    Vella V; Malaguarnera R; Nicolosi ML; Palladino C; Spoleti C; Massimino M; Vigneri P; Purrello M; Ragusa M; Morrione A; Belfiore A
    Oncotarget; 2017 Jun; 8(26):43248-43270. PubMed ID: 28591735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of transmembrane receptor tyrosine kinase DDR1-STAT3 cascade by extracellular matrix remodeling promotes liver metastatic colonization in uveal melanoma.
    Dai W; Liu S; Wang S; Zhao L; Yang X; Zhou J; Wang Y; Zhang J; Zhang P; Ding K; Li Y; Pan J
    Signal Transduct Target Ther; 2021 May; 6(1):176. PubMed ID: 33976105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDR1 and DDR2 physical interaction leads to signaling interconnection but with possible distinct functions.
    Croissant C; Tuariihionoa A; Bacou M; Souleyreau W; Sala M; Henriet E; Bikfalvi A; Saltel F; Auguste P
    Cell Adh Migr; 2018; 12(4):324-334. PubMed ID: 29616590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
    Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma.
    Berestjuk I; Lecacheur M; Carminati A; Diazzi S; Rovera C; Prod'homme V; Ohanna M; Popovic A; Mallavialle A; Larbret F; Pisano S; Audebert S; Passeron T; Gaggioli C; Girard CA; Deckert M; Tartare-Deckert S
    EMBO Mol Med; 2022 Feb; 14(2):e11814. PubMed ID: 34957688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A putative role for Discoidin Domain Receptor 1 in cancer chemoresistance.
    Ambrogio C; Darbo E; Lee SW; Santamaría D
    Cell Adh Migr; 2018; 12(4):394-397. PubMed ID: 29505315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1) Is a Novel Therapeutic Target in Liposarcoma: A Tissue Microarray Study.
    Dean DC; Feng W; Walker RL; Thanindratarn P; Temple HT; Trent JC; Rosenberg AE; Hornicek FJ; Duan Z
    Clin Orthop Relat Res; 2023 Nov; 481(11):2140-2153. PubMed ID: 37768856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live cell measurements of interaction forces and binding kinetics between Discoidin Domain Receptor 1 (DDR1) and collagen I with atomic force microscopy.
    Sarkar A; Sohail A; Dong J; Prunotto M; Shinki K; Fridman R; Hoffmann PM
    Biochim Biophys Acta Gen Subj; 2019 Nov; 1863(11):129402. PubMed ID: 31351093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma.
    Aguilera KY; Huang H; Du W; Hagopian MM; Wang Z; Hinz S; Hwang TH; Wang H; Fleming JB; Castrillon DH; Ren X; Ding K; Brekken RA
    Mol Cancer Ther; 2017 Nov; 16(11):2473-2485. PubMed ID: 28864681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.